Rocaglamide, a natural product, could enhance the natural killer cell-mediated lysis of NSCLC cells by targeting ULK1, which is required for autophagy initiation and autophagy inhibition [29]. The gene discussed is ULK1; the disease is non-small cell lung carcinoma.